Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-1029-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Oral Contraceptive Use and Ovarian Cancer Risk Among Carriers of BRCA1 or BRCA2 Mutations

British Journal of Cancer
Cancer ResearchOncology
2004English

Uterine Cancer in Jewish Israeli BRCA1/BRCA2 Mutation Carriers

Cancer
Cancer ResearchOncology
2018English

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer

Cancers
Cancer ResearchOncology
2018English

Plasma Osteoprotegerin and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Oncotarget
Oncology
2016English

Salpingo-Oophorectomy and the Risk of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women With a BRCA1 or BRCA2 Mutation

JAMA - Journal of the American Medical Association
Medicine
2006English

Brca1/Brca2

2019English

The Role of BRCA1 and BRCA2 Mutations in Prostate, Pancreatic and Stomach Cancers

Hereditary Cancer in Clinical Practice
OncologyGenetics
2015English

Uptake and Timing of Bilateral Prophylactic Salpingo-Oophorectomy Among BRCA1 and BRCA2 Mutation Carriers

Genetics in Medicine
MedicineGenetics
2008English

Annual Screening Strategies in BRCA1 and BRCA2 Gene Mutation Carriers: A Comparative Effectiveness Analysis

Breast Diseases
OncologySurgery
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy